Systems and methods for the fabrication of tablets, including pharmaceutical tablets

US11020352B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11020352-B2
Application numberUS-202016883909-A
CountryUS
Kind codeB2
Filing dateMay 26, 2020
Priority dateFeb 17, 2017
Publication dateJun 1, 2021
Grant dateJun 1, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods for fabricating ingestible pharmaceutical tablets are provided. Certain of the systems and methods described herein are capable of manufacturing tablets of different dosages without the need to fluidically connect or disconnect unit operations when switching from a tablet having a first dosage to a tablet having a second, different dosage. Certain of the systems and methods described herein are capable of manufacturing compositionally tablets, e.g., tablets with different active pharmaceutical ingredients (APIs).

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing an ingestible pharmaceutical composition, comprising: receiving, with a controller, instructions regarding a first tablet dosage and a second tablet dosage; dispensing a first amount of a solid active pharmaceutical ingredient; dispensing a first amount of an excipient; blending the first amount of the solid active pharmaceutical ingredient and the first amount of the excipient to form a first mixture having a volume of less than 10 L; forming a first tablet from the first mixture; dispensing a second amount of the solid active pharmaceutical ingredient; dispensing a second amount of the excipient; blending the second amount of the solid active pharmaceutical ingredient and the second amount of the excipient to form a second mixture; and forming a second tablet from the second mixture, wherein a dosage of the active pharmaceutical ingredient of the first tablet is different from a dosage of the active pharmaceutical ingredient of the second tablet, wherein at least one of the dispensing steps is performed using a dispenser comprising an outlet and containing a plurality of beads having a size larger than that of the outlet of the dispenser. 2. The method of claim 1 , further comprising: weighing the first amount of the solid active pharmaceutical ingredient and the first amount of the excipient; and weighing the second amount of the solid active pharmaceutical ingredient and the second amount of the excipient. 3. The method of claim 1 , wherein the first mixture has a volume of less than or equal to 1 L. 4. The method of claim 1 , further comprising dispensing a portion of the first mixture to form the first tablet. 5. The method of claim 4 , further comprising compressing the portion of the first mixture to form the first tablet. 6. The method of claim 1 , further comprising weighing the first tablet and weighing the second tablet. 7. The method of claim 1 , wherein the blending is performed by a blender, further comprising opening a portion of the blender to release the first mixture. 8. The method of claim 7 , further comprising moving the first mixture from the blender to a dispenser. 9. The method of claim 1 , wherein instructions regarding the second tablet dosage are received at a different point in time than instructions regarding the first tablet dosage, and wherein the step of dispensing the second amount of the solid active pharmaceutical ingredient is in response to the instructions regarding the second tablet dosage. 10. The method of claim 1 , wherein the second amount of the solid active pharmaceutical ingredient is different from the first amount of the solid active pharmaceutical ingredient. 11. The method of claim 1 , wherein the second amount of the solid active pharmaceutical ingredient is the same as the first amount of the solid active pharmaceutical ingredient. 12. The method of claim 1 , wherein the second amount of the excipient is different from the first amount of the excipient. 13. The method of claim 1 , wherein the second amount of the excipient is the same as the first amount of the excipient. 14. The method of claim 1 , wherein the solid active pharmaceutical ingredient is selected from the group consisting of: ibuprofen, doxycycline monohydrate, diphenhydramine hydrochloride, diazepam, ciprofloxacin HCl, azithromycin and fluoxetine hydrochloride. 15. The method of claim 1 , wherein at least one of the dispensing, blending and tableting steps are carried out at least partially in response to the instructions. 16. The method of claim 1 , wherein the second mixture has a volume of less than or equal to 10 L. 17. The method of claim 1 , further comprising: receiving, with a controller, instructions regarding a first drug type and a second drug type; and dispensing a second solid active pharmaceutical ingredient, the second solid active pharmaceutical ingredient being compositionally different from the solid active pharmaceutical ingredient. 18. The method of claim 1 , wherein the solid active pharmaceutical ingredient and the excipient are dispensed from a plurality of dispensers and the blending is performed in a blender, the plurality of dispensers and the blender being coupled to a frame. 19. A method of producing an ingestible pharmaceutical composition, comprising: receiving, with a controller, instructions regarding a first tablet dosage and a second tablet dosage; dispensing a first amount of a solid active pharmaceutical ingredient from a first dispenser; dispensing a first amount of an excipient from a second dispenser; blending the first amount of the solid active pharmaceutical ingredient and the first amount of the excipient in a blender to form a first mixture; forming a first tablet from the first mixture; dispensing a second amount of the solid active pharmaceutical ingredient from the first dispenser; dispensing a second amount of the excipient from the second dispenser; blending the second amount of the solid active pharmaceutical ingredient and the second amount of the excipient in the blender to form a second mixture; and forming a second tablet from the second mixture, wherein the first dispenser, the second dispenser and the blender are coupled to a frame, and wherein the first dispenser and/or the second dispenser comprises an outlet and contains a plurality of beads having a size larger than that of the outlet. 20. A method of producing an ingestible pharmaceutical composition, comprising: receiving, with a controller, instructions regarding a first drug type and a second drug type; dispensing a first solid active pharmaceutical ingredient; dispensing a first excipient; blending the first solid active pharmaceutical ingredient and the first excipient to form a first mixture having a volume of less than 10 L; forming a tablet from the first mixture; dispensing a second solid active pharmaceutical ingredient, the second solid active pharmaceutical ingredient being compositionally different from the first solid active pharmaceutical ingredient; dispensing a second excipient; blending the second solid active pharmaceutical ingredient and the second excipient to form a second mixture; and forming a tablet from the second mixture, wherein at least one of the dispensing steps is performed using a dispenser comprising a plurality of beads and an outlet, the beads having a size larger than that of the outlet. 21. The method of claim 20 , further comprising: weighing the first solid active pharmaceutical ingredient and the first excipient; and weighing the second solid active pharmaceutical ingredient and the second excipient. 22. The method of claim 20 , further comprising weighing the tablet from the first mixture and weighing the tablet from the second mixture. 23. A system for producing an ingestible pharmaceutical composition, comprising: a plurality of dispensers; a first weigh scale configured to weigh material dispensed from the plurality of dispensers; a blender configured to receive and mix the material dispensed from the plurality of dispensers to form a first mixture, the blender having a mixing vessel having a volume of less than 10 L; and a plurality of beads within at least one of the dispensers, the beads having a size larger than that of an outlet of the at least one of the dispensers. 24. The system of claim 23 , further comprising a secondary dispenser that is configured t

Assignees

Inventors

Classifications

  • having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid  {(cannabinoids A61K31/658)} · CPC title

  • Feeding material in particulate or plastic state to moulding presses · CPC title

  • Mixing of ingredients for pharmaceutical or medical compositions · CPC title

  • with means for customizing the mixture on the point of sale, e.g. by sensing, receiving or analysing information about the characteristics of the mixture to be made · CPC title

  • using a computer for controlling information and converting it in a formula and a set of operation instructions, e.g. on the point of sale · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11020352B2 cover?
Systems and methods for fabricating ingestible pharmaceutical tablets are provided. Certain of the systems and methods described herein are capable of manufacturing tablets of different dosages without the need to fluidically connect or disconnect unit operations when switching from a tablet having a first dosage to a tablet having a second, different dosage. Certain of the systems and methods …
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification A61K9/2095. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).